Company profile
Vicore Pharma Holding AB
NASDAQ: VCRE · Healthcare · Biotechnology
PublicHQ Solna, CIK 0002124403Reports USD
#1 of 1,418 Healthcare companies by revenue
EA Score
——FH —DQ —GM —SS 46
v0.1 · 5/100 weight · pillars only
↑ market scale, workforce scale · ↓ listing tenure, workforce scale
Methodology →Revenue TTM
—
Rev growth YoY (TTM)
needs 8 qtrs
Net income (FY)
—
Employees
37
as of 2026-08-08
Market cap
$3.4B
as of 2026-08-08
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
No filed financials — private or non-XBRL filer.
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is Vicore Pharma Holding AB’s financial profile?
Vicore Pharma Holding AB has no structured financials on file — private or non-XBRL filer.
Peers · Healthcare
Enliven Therapeutics, Inc.——Legend Biotech Corporation——Galera Therapeutics, Inc.——MBX Biosciences, Inc. Common Stock——Structure Therapeutics Inc.——Disc Medicine, Inc.——Key facts
CEOAhmed Mousa
SectorHealthcare
IndustryBiotechnology
HeadquartersSolna, null
ExchangeNASDAQ: VCRE
Employees37
IPO date2026-07-02
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.